Investor Relations

Orexo's share is listed on NasdaqOMX Stockholm, Sweden (ORX), and is available as American Depository Receipts on OTCQX market in the US (OXROY).

Share price

Name
0.00
0 SEK (0%)
HH:MM CET • 20YY-MM-DD

Latest CEO Comments

JULY 14, 2022

"Good tailwind in the financial development"

Read the latest CEO comments from Nikolaj Sørensen

Key financial figures

Group net revenue

597 MSEK
Last Twelve Months, Q321-Q222

Group EBITDA

-126 MSEK
Last Twelve Months, Q321-Q222

US Pharma segment EBIT

312 MSEK
Last Twelve Months, Q321-Q222

Cash position

468 MSEK
Q222
IR-Contact